Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThese changes are administrative UI and metadata updates (Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0) with the removal of similar prior items (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4); they do not modify core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This change does not affect any clinical trial details or content such as study results, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded a consolidated Locations section listing California and Texas recruitment sites (replacing separate location blocks). Updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.4%

- Check64 days agoChange DetectedRevision: v3.3.2 has replaced v3.3.1 on the page; it is a minor version update and does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page's changelog. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedThe notice about potential government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.